Overview
2. Epidemiologic studies to better understand the causes and variability in prognosis of amyotrophic lateral sclerosis and diabetic neuropathy.
3. Basic science studies to develop novel biomarkers for amyotrophic lateral sclerosis.
Current Appointments & Affiliations
Stewart, Hughes and Wendt Distinguished Professor
·
2023 - Present
Neurology, Neuromuscular Disease,
Neurology
Professor of Neurology
·
2018 - Present
Neurology, Neuromuscular Disease,
Neurology
Faculty Network Member of the Duke Institute for Brain Sciences
·
2011 - Present
Duke Institute for Brain Sciences,
University Institutes and Centers
Associate of the Duke Initiative for Science & Society
·
2017 - Present
Duke Science & Society,
University Initiatives & Academic Support Units
Recent Publications
Overstating harms can have consequences.
Journal Article Brain · June 3, 2025 Full text Link to item CiteALSUntangled #79: alpha-lipoic acid.
Journal Article Amyotroph Lateral Scler Frontotemporal Degener · May 24, 2025 Alpha-lipoic acid (ALA) is a naturally occurring fatty acid. It serves as an essential cofactor for enzymatic reactions in mitochondrial energy production, is a potent antioxidant and has anti-inflammatory effects, which are plausible mechanisms in slowing ... Full text Link to item CiteALSUntangled #77: Psilocybin.
Journal Article Amyotroph Lateral Scler Frontotemporal Degener · May 2025 ALSUntangled reviews alternate and off-label treatments prompted by patient interest. Here, we review psilocybin, a chemical derived from mushrooms and belonging in the category of drugs known as psychedelics. Psilocybin has plausible mechanisms for slowin ... Full text Link to item CiteRecent Grants
Pridopine EAP 2 (Clinical Site Agreement)
ResearchPrincipal Investigator · Awarded by Massachusetts General Hospital · 2024 - 2027An Intermediate Expanded Access Protocol (EAP) with CNM-Au8 for Amyotrophic Lateral Sclerosis
ResearchPrincipal Investigator · Awarded by Clene Nanomedicine Inc. · 2024 - 2026Pilot Trial to Investigate The Safety, Tolerability and Preliminary Efficacy of BL-001 Probiotic in People with ALS
Clinical TrialPrincipal Investigator · Awarded by Hop On A Cure · 2024 - 2026View All Grants
Education, Training & Certifications
University of Connecticut ·
1995
M.D.
University of Connecticut ·
1995
Ph.D.